GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.
GSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent rights in mRNA-vaccine innovations developed "more than a decade before" the outbreak of the COVID-19 pandemic.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- Comirnaty
- Pfizer
- GlaxoSmithKline
- Delaware
- COVID-19
- messenger RNA
Advertisement
ALSO READ
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Health News Roundup: GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology; Gilead posts quarterly loss, revenue rises 5% and more